These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 47136)

  • 21. The dynamics of life. I. Death from internal irradiation by 239Pu and 226Ra, aging, cancer, and other diseases.
    Stover BJ; Eyring H
    Proc Natl Acad Sci U S A; 1970 May; 66(1):132-9. PubMed ID: 5273891
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comments on "Two-mutation models for bone cancer due to radium, strontium and plutonium" by Bijwaard et al. (Radiat. Res. 162, 171-184, 2004).
    Lloyd RD; Miller SC; Taylor GN; Bruenger FW; Jee WS
    Radiat Res; 2005 Dec; 164(6):828; author reply 828-9. PubMed ID: 16296890
    [No Abstract]   [Full Text] [Related]  

  • 23. Dose to endosteal cells and relative distribution factors for radium-224 and plutonium-239 compared to radium-226.
    Marshall JH; Groer PG; Schlenker RA
    Health Phys; 1978 Jul; 35(1):91-101. PubMed ID: 721487
    [No Abstract]   [Full Text] [Related]  

  • 24. The relative toxicities of radium 226, plutonium 239 and strontium 90 for bone tumour induction.
    Hems G; Mole RH
    Br J Radiol; 1966 Oct; 39(466):719-26. PubMed ID: 5926612
    [No Abstract]   [Full Text] [Related]  

  • 25. Radiation dose-time relations for induction of osteosarcoma in mice and dogs and their bearing on maximal permissible burden of 90 Sr in man.
    Blair HA
    Health Phys; 1972 Dec; 23(6):759-65. PubMed ID: 4509055
    [No Abstract]   [Full Text] [Related]  

  • 26. The microdistribution and retention of injected 239Pu on trabecular bone surfaces of the beagle: implications for the induction of osteosarcoma.
    Wronski TJ; Smith JM; Jee WS
    Radiat Res; 1980 Jul; 83(1):74-89. PubMed ID: 6930688
    [No Abstract]   [Full Text] [Related]  

  • 27. The calculation of annual limits of intake for plutonium-239 in man using a bone model which allows for plutonium burial and recycling.
    Priest ND; Hunt BW
    Phys Med Biol; 1979 May; 24(3):525-46. PubMed ID: 461512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late effects of 226Ra, 224Ra and 239Pu in female mice of the ICR strain.
    Kofránek V; Sedlák A; Bubeníková D; Dvorák V
    Strahlentherapie Sonderb; 1985; 80():88-92. PubMed ID: 3868210
    [No Abstract]   [Full Text] [Related]  

  • 29. The uptake of plutonium in bone marrow: a possible leukaemic risk.
    Vaughan J; Bleaney B; Williamson M
    Br J Haematol; 1967 Jul; 13(4):492-502. PubMed ID: 5230409
    [No Abstract]   [Full Text] [Related]  

  • 30. Bone-seeking radionuclides.
    Mays CW
    Science; 1968 Aug; 161(3843):814. PubMed ID: 5243072
    [No Abstract]   [Full Text] [Related]  

  • 31. Dose rates, dose and time effects of 90Sr + 90Y and 226Ra on beagle skeleton.
    Momeni MH; Williams JR; Jow N; Rosenblatt LS
    Health Phys; 1976 May; 30(5):381-90. PubMed ID: 1270266
    [No Abstract]   [Full Text] [Related]  

  • 32. Toxicity of inhaled plutonium dioxide in beagle dogs.
    Muggenburg BA; Guilmette RA; Mewhinney JA; Gillett NA; Mauderly JL; Griffith WC; Diel JH; Scott BR; Hahn FF; Boecker BB
    Radiat Res; 1996 Mar; 145(3):361-81. PubMed ID: 8927705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the dose to cells on trabecular bone surfaces from plutonium-239 and radium-226 based on experimental alpha absorption measurements.
    Harley NH; Pasternack BS
    Health Phys; 1976 Jan; 30(1):35-46. PubMed ID: 1244336
    [No Abstract]   [Full Text] [Related]  

  • 34. [Distribution of absorbed doses in the organs of patients during roetgenodiagnosis].
    Telichko FF
    Med Radiol (Mosk); 1973 Oct; 18(10):36-44. PubMed ID: 4790639
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparative study of hazards of energy plutonium and standard Pu-239 using non stochastic effects].
    Kalmykova ZI; Liubchanskiĭ ER; Chudin VA; Sokhranich AL; Muksinova KN; Kirillova EN; Karpova VN; Kaminskaia TV; Spirina SS
    Radiats Biol Radioecol; 1996; 36(1):94-103. PubMed ID: 8696493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution and toxicity of monomeric and polymeric 239Pu in immature and adult rats.
    Mahlum DD; Sikov MR
    Radiat Res; 1974 Oct; 60(1):75-88. PubMed ID: 10881701
    [No Abstract]   [Full Text] [Related]  

  • 37. Dose delivered to various bone and marrow sites of radium 226 injected mice related to the observed heterogeneity in damage to haemopoietic marrow cells.
    Schoeters GE
    Br J Radiol; 1982 Jul; 55(655):520-9. PubMed ID: 7150901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone sarcomas in 239Pu-treated mice.
    Svoboda V; Klener V; Bubeníková D; Globocnik E
    Neoplasma; 1980; 27(1):3-10. PubMed ID: 6929411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative toxicity of 226Ra, 239Pu, 241Am, 249Cf, and 252Cf in C57BL/Do black and albino mice.
    Taylor GN; Mays CW; Lloyd RD; Gardner PA; Talbot LR; McFarland SS; Pollard TA; Atherton DR; VanMoorhem D; Brammer D; Brammer TW; Ayoroa G; Taysum DH
    Radiat Res; 1983 Sep; 95(3):584-601. PubMed ID: 6611863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case study of selected medical findings among plutonium injectees.
    Stebbings JH
    Health Phys; 1999 May; 76(5):477-88. PubMed ID: 10201560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.